Summary
The European Parliament opposes the authorization of MON 810 genetically modified maize, citing insufficient safety studies and legal concerns. 10 06.10.2016
Other
health
environment
agri-foodstuffs
agriculture, forestry and fisheries
Key points
- The motion opposes the authorization of MON 810 genetically modified maize products for the market.
- There is a significant concern regarding the lack of long-term studies on toxicity and feeding safety.
- EU Member States have shown deep division, with many voting against or abstaining from the decision.
- The draft decision is viewed as exceeding the legal powers granted to the Commission.
Documents (PDFs)
MOTION FOR A RESOLUTION on the draft Commission implementing decision authorising the placing on the market of genetically modified maize MON 810 (MON-ØØ81Ø-6) products pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council
Placing on the market of genetically modified maize MON 810 products
These raw data are provided by the Open Data Portal of the European Union (data.europa.eu) and are licensed under ODC-BY 1.0.